July 30, 2014 1:27 PM ET

Capital Markets

Company Overview of Sequoia Capital India

Company Overview

Sequoia Capital India is a venture capital firm specializing in investments in startup, seed, early, mid, late, expansion, public and growth stage companies. The firm prefers to invest in the information technology companies with a focus on the emerging India-US cross border companies in the big data analytics, enterprise software, and semiconductors sectors. It seeks to invest in the consumer services, energy, financial services, infrastructure, healthcare services, internet, mobile applications, outsourcing, wireless and technology sectors. Within consumer services it invests in agriculture, distribution, education, hospitality, media, retail, packaged goods, and enabling technology. Withi...

The Millenia, Tower A

11th Floor

No 1&2

Murphy Road, Ulsoor

Bangalore,  560008

India

Founded in 2000

Phone:

91 80 4124 5880

Fax:

91 80 4124 5884

Key Executives for Sequoia Capital India

Managing Director
Age: 44
Managing Director and Partner
Managing Director and Partner
Age: 37
Managing Director and Partner
Managing Director and Partner
Compensation as of Fiscal Year 2014.

Sequoia Capital India Key Developments

Sequoia Capital India Presents at 7th Annual SuperReturn U.S. conference, Jun-11-2014 09:40 AM

Sequoia Capital India Presents at 7th Annual SuperReturn U.S. conference, Jun-11-2014 09:40 AM. Venue: Renaissance Boston Waterfront Hotel, 606 Congress Street, Boston, MA 02210, United States. Speakers: Sumir Chadha, Co-founder & Managing Director.

Vasan Reportedly Raising $50 Million

Vasan Healthcare Pvt. Ltd. is raising $50 million in fresh funds from its existing investors Sequoia Capital India; GIC Pte. Ltd.; and WestBridge Capital at the valuation of $600 million, people familiar with the development said. The fund-raise is being done through a rights issue - an issue of shares offered at a special price by a company to its existing shareholders - and will see Vasan's promoter A M Arun also participate, sources added. A M Arun currently holds about 55% stake while the three investors together hold 45% stake. Sources said Vasan had drawn interest from a few strategic investors, but it may eventually opt for a public offering over the next year or so. The rights issue was pre-determined during the last round of funding, when GIC had invested, if the company met performance milestones, sources said. The $50 million of fresh funds will be used for expanding the reach of the chain as the group looks to diversify into other areas of healthcare. According to Times of India, calls and text messages sent Arun went unanswered while Sequoia and WestBridge declined to comment.

Sequoia Capital Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014

Sequoia Capital Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014 . Venue: Kempinski Hotel Suzhou, Suzhou, China.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 28, 2014
Knowlarity Communications Pvt. Ltd.
Private Placement
July 17, 2014
Capillary Technologies Pvt. Ltd.
Private Placement
July 1, 2014
Milky Mist Dairy Foods Private Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sequoia Capital India, please visit www.sequoiacap.com/india/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.